Standout Papers

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice 2021 2026 2022 2024194
  1. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice (2021)
    Eriya Kenjo, Hiroyuki Hozumi et al. Nature Communications

Immediate Impact

1 by Nobel laureates 14 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
2025 Standout
Past, present, and future of CRISPR genome editing technologies
2024 Standout
2 intermediate papers

Works of Yuichiro Amano being referenced

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
2021 Standout
FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats.
1996
and 1 more

Author Peers

Author Last Decade Papers Cites
Yuichiro Amano 524 165 106 113 31 788
William McDowell 380 71 93 56 25 756
Roni Oren 419 211 45 99 27 980
Robert Haas 470 69 71 46 19 859
Ju Bao 507 55 130 31 28 815
Yong‐Kyung Choe 629 79 105 59 30 972
Valentina Condelli 554 55 90 34 31 822
Robert E. Corin 309 102 59 71 27 688
Tsutomu Tanaka 413 98 222 27 36 951
Rachel Avner 420 202 320 26 18 918
Xiaoyu Cao 463 64 110 96 52 852

All Works

Loading papers...

Rankless by CCL
2026